Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» BAY94-9027
BAY94-9027
Bayer Secures FDA Approval for Hemophilia A Treatment, Jivi
BioSpace
Thu, 08/30/18 - 10:13 am
hemophilia A
Bayer
FDA
Jivi
BAY94-9027
Bayer files longer-acting bleeding candidate to FDA
Fierce Biotech
Fri, 09/1/17 - 10:15 am
Bayer
FDA
BAY94-9027
hemophilia A
Bayer cites success in hemophilia study, but may still trail Biogen Idec
Fierce Biotech
Tue, 02/18/14 - 10:33 am
Bayer
Biogen Idec
hemophilia
BAY94-9027
Factor VIII
Bayer Initiates Phase II/III Trial of New Recombinant Factor VIII Compound for Treatment of Hemophilia A
news.genom.es
Sun, 07/8/12 - 01:26 pm
Bayer
hemophilia
BAY94-9027